Induction Agents for Tracheal Intubation in Critically Ill Patients

Area of Science:

• Critical care medicine
• Pharmacology
• Emergency medicine

Background:

• Tracheal intubation is a common procedure in critically ill patients.
• The choice of induction agent can significantly impact patient outcomes.
• Existing evidence on induction agents in critical care is often limited.

Purpose of the Study:

• To review the use of induction agents for tracheal intubation in critically ill patients.
• To assess the association between different induction agents and patient outcomes.
• To provide evidence-based recommendations for drug selection in critical care settings.

Main Methods:

• Systematic review of original publications retrieved via PubMed search.
• Inclusion of randomized controlled trials and observational studies reporting patient outcomes.
• Extraction of data on induction agent choice and clinically relevant outcomes.

Main Results:

• Ketamine and etomidate are the most studied induction agents.
• Etomidate may be associated with increased mortality and lacks clear hemodynamic benefits over ketamine.
• Propofol is linked to post-intubation cardiovascular instability in observational data.

Conclusions:

• Ketamine appears to have a safer profile compared to etomidate and propofol.
• Etomidate may negatively affect survival, and propofol is associated with cardiovascular instability.
• Future research should focus on optimal drug selection, dosing, and interventions to minimize peri-intubation complications.